Company · CIK 1863127

# Tyra Biosciences, Inc.

| CIK | [1863127](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001863127) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | TYRA (Nasdaq) |
| First annual or quarterly report | 2021-11-03 |

## Offerings

 5 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-298911 | Shelf Effective | 2026-09-14 | 2026-09-15 | 2 |
| 333-287086 | Shelf Effective | 2025-05-08 | 2026-08-04 | 3 |
| 333-278068 | Shelf Effective | 2024-03-19 | 2024-04-22 | 2 |
| 333-267712 | Shelf Effective | 2022-10-03 | 2022-10-13 | 2 |
| 333-258970 | IPO Final prospectus | 2021-08-20 | 2021-09-15 | 5 |

## Filings

 15

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-09-15 | [424B5](https://www.sec.gov/Archives/edgar/data/1863127/000119312526390947/0001193125-26-390947-index.htm) Shelf takedown | 333-298911 | 0001193125-26-390947 |
| 2026-09-14 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1863127/000119312526389752/0001193125-26-389752-index.htm) Shelf registered | 333-298911 | 0001193125-26-389752 |
| 2026-08-04 | [424B5](https://www.sec.gov/Archives/edgar/data/1863127/000119312526333055/0001193125-26-333055-index.htm) Shelf takedown | 333-287086 | 0001193125-26-333055 |
| 2025-05-16 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1863127/999999999525001644/9999999995-25-001644-index.htm) Declared effective | 333-287086 | 9999999995-25-001644 |
| 2025-05-08 | [S-3](https://www.sec.gov/Archives/edgar/data/1863127/000119312525116008/0001193125-25-116008-index.htm) Shelf registered | 333-287086 | 0001193125-25-116008 |
| 2024-04-22 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1863127/999999999524001069/9999999995-24-001069-index.htm) Declared effective | 333-278068 | 9999999995-24-001069 |
| 2024-03-19 | [S-3](https://www.sec.gov/Archives/edgar/data/1863127/000119312524071361/0001193125-24-071361-index.htm) Shelf registered | 333-278068 | 0001193125-24-071361 |
| 2022-10-13 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1863127/999999999522003041/9999999995-22-003041-index.htm) Declared effective | 333-267712 | 9999999995-22-003041 |
| 2022-10-03 | [S-3](https://www.sec.gov/Archives/edgar/data/1863127/000119312522256638/0001193125-22-256638-index.htm) Shelf registered | 333-267712 | 0001193125-22-256638 |
| 2021-09-15 | [424B4](https://www.sec.gov/Archives/edgar/data/1863127/000119312521273963/0001193125-21-273963-index.htm) Final prospectus | 333-258970 | 0001193125-21-273963 |
| 2021-09-14 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1863127/999999999521003510/9999999995-21-003510-index.htm) Declared effective | 333-258970 | 9999999995-21-003510 |
| 2021-09-14 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1863127/000119312521272111/0001193125-21-272111-index.htm) Amendment | 333-258970 | 0001193125-21-272111 |
| 2021-09-09 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1863127/000119312521268272/0001193125-21-268272-index.htm) Amendment | 333-258970 | 0001193125-21-268272 |
| 2021-08-20 | [S-1](https://www.sec.gov/Archives/edgar/data/1863127/000119312521252729/0001193125-21-252729-index.htm) Registration filed | 333-258970 | 0001193125-21-252729 |
| 2021-05-28 | [DRS](https://www.sec.gov/Archives/edgar/data/1863127/000095012321007433/0000950123-21-007433-index.htm) Draft made public | 377-04947 | 0000950123-21-007433 |

[All filings of this company](https://equitycapital.markets/filings?cik=1863127) · [CSV](https://equitycapital.markets/filings.csv?cik=1863127)

---
Source page: https://equitycapital.markets/company/1863127 · Data: U.S. SEC EDGAR · CC BY 4.0